174 related articles for article (PubMed ID: 1795468)
21. [Tolerance for the antianginal effect of nitrates. Approaches to its study].
Martsevich SIu; Shakarova SSh; Metelitsa VI; Strel'tsov AA; Vygodin VA
Ter Arkh; 1984; 56(9):46-50. PubMed ID: 6515547
[TBL] [Abstract][Full Text] [Related]
22. Relation of antianginal efficacy of nifedipine to degree of coronary arterial narrowing and to presence of coronary collateral vessels.
Schulz W; Jost S; Kober G; Kaltenbach M
Am J Cardiol; 1985 Jan; 55(1):26-32. PubMed ID: 3881006
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the efficacy and duration of action of isosorbide mononitrate in angina pectoris.
de Belder MA; Schneeweiss A; Camm AJ
Am J Cardiol; 1990 Jun; 65(21):6J-8J. PubMed ID: 2190464
[TBL] [Abstract][Full Text] [Related]
24. The daylong pattern of the antianginal effect of long-term three times daily administered isosorbide dinitrate.
Bassan MM
J Am Coll Cardiol; 1990 Oct; 16(4):936-40. PubMed ID: 2212374
[TBL] [Abstract][Full Text] [Related]
25. [A new antianginal preparation: isosorbide-5-mononitrate].
Martsevich SIu; Metelitsa VI; Slastnikova ID; Simkhaev LS; Egorov LV; Blagodatskikh SV
Kardiologiia; 1990 Oct; 30(10):44-6. PubMed ID: 2290270
[TBL] [Abstract][Full Text] [Related]
26. A comparison of nifedipine and isosorbide dinitrate in angina pectoris with particular reference to arterial oxygen saturation.
Tirlapur VG; Mir MA
Postgrad Med J; 1983; 59 Suppl 2():30-4. PubMed ID: 6136959
[TBL] [Abstract][Full Text] [Related]
27. [Antianginal and anti-ischemic effects of Mono Mac 50D preparation as an agent in combined treatment of patients with stable angina].
Demchenko EA; Berezina AV; Panov AV
Klin Med (Mosk); 2002; 80(9):57-9. PubMed ID: 12416229
[No Abstract] [Full Text] [Related]
28. The antianginal efficacy of isosorbide dinitrate: dose-response relation and long-term effects of high-dose treatment.
Schneider W; Bussmann WD; Stahl B; Wietschoreck A; Kaltenbach M
Z Kardiol; 1985; 74 Suppl 1():55-63. PubMed ID: 3922143
[No Abstract] [Full Text] [Related]
29. Effects of long-term oral administration of isosorbide dinitrate on the antianginal response to nitroglycerin. Absence of nitrate cross-tolerance and self-tolerance shown by exercise testing.
Lee G; Mason DT; De Maria AN
Am J Cardiol; 1978 Jan; 41(1):82-7. PubMed ID: 414612
[No Abstract] [Full Text] [Related]
30. The efficacy of isosorbide-5-mononitrate on effort-induced electrocardiographic ischemic changes in patients with angina pectoris.
Brunner D; Meshulam N; Weisbort J
Int J Cardiol; 1987 Sep; 16(3):303-7. PubMed ID: 3654028
[TBL] [Abstract][Full Text] [Related]
31. [The effect of diuretics on the magnitude of the effect of isosorbide dinitrate given as a single dose and after long-term administration. Ergometric study in patients with stable angina pectoris].
Rotrekl P; Vlasínová J; Manousek J; Bocek O; Vlasicová Y; Janousek S; Semrád B
Vnitr Lek; 1994 Nov; 40(11):693-7. PubMed ID: 7810090
[TBL] [Abstract][Full Text] [Related]
32. [Possibility of developing tolerance to the anti-anginal effect of isosorbide dinitrate and verapamil].
Metelitsa VI; Shakarova SSh; Martsevich SIu; Vygodin VA; Strel'tsov AA
Kardiologiia; 1985 Jan; 25(1):63-7. PubMed ID: 3920428
[TBL] [Abstract][Full Text] [Related]
33. Propranolol and isosorbide dinitrate synergism in angina pectoris.
Russek HI
Am J Cardiol; 1968 Jan; 21(1):44-54. PubMed ID: 5634742
[No Abstract] [Full Text] [Related]
34. Propranolol combined with isosorbide dinitrate versus placebo in angina pectoris.
Aronow WS; Kaplan MA
N Engl J Med; 1969 Apr; 280(16):847-50. PubMed ID: 4975605
[No Abstract] [Full Text] [Related]
35. Comparison of antianginal efficacy of sustained release isosorbide dinitrate with short-acting isosorbide dinitrate.
Joseph G
Indian Heart J; 1991; 43(6):477. PubMed ID: 1823901
[No Abstract] [Full Text] [Related]
36. Withdrawal effects of antianginal therapy: comparison of isosorbide dinitrate and nifedipine.
Martsevich SYu ; Koutishenko N; Metelitsa VI
Int J Cardiol; 1998 Apr; 64(2):137-44. PubMed ID: 9688432
[TBL] [Abstract][Full Text] [Related]
37. Antianginal efficacy of oral therapy with isosorbide dinitrate capsules. Prolonged benefit shown by exercise testing in patients with ischemic heart disease.
Lee G; Mason DT; Amsterdam EA; Miller RR; DeMaria AN
Chest; 1978 Mar; 73(3):327-32. PubMed ID: 344006
[No Abstract] [Full Text] [Related]
38. [The relationship between the isosorbide-5-mononitrate concentration and its antianginal effect following the administration of regular and prolonged-action drug forms in patients with stenocardia of effort].
Blagodatskikh SV; Martsevich SIu; Metelitsa VI; Kutishenko NP; Kozyreva MP; Simkhaev LS; Slastinkova ID; Vakulovskaia MK
Eksp Klin Farmakol; 1995; 58(3):25-7. PubMed ID: 7663289
[TBL] [Abstract][Full Text] [Related]
39. [Comparative evaluation of antianginal efficacy of isosorbide dinitrate in various doses in patients with stable angina].
Kośmicki M; Sadowski Z
Wiad Lek; 2000; 53(7-8):388-93. PubMed ID: 11070759
[TBL] [Abstract][Full Text] [Related]
40. Importance of coronary collateral circulation for increased treadmill exercise capacity by nitrates in patients with stable effort angina pectoris.
Ohno A; Fujita M; Miwa K; Ejiri M; Asanoi H; Sasayama S
Cardiology; 1991; 78(4):323-8. PubMed ID: 1889050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
